PPIs, clopidogrel, and stents
Links shared publicly online about this topic.
- 1,125total visits
PPIs, clopidogrel, and stents
View full resource at theheart.org
Tags: GERD Medication, Zollinger-Ellison Syndrome Medication, Heartburn Medication, H pylori Infection Medication, FDA, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on June 1, 2010 at 10:38 pm By:
PPIs, clopidogrel, and stent implantation: No risk? FDA data coming soon: Another retrospective analysis, this tim... http://bit.ly/akQLR8
Clopidogrel and adverse cardiovascular events not linked - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – There is no need to avoid proton pump inhibitors (PPIs) in patients on the platelet inhibitors clopidogrel or ticagrelor. The increased rates of adverse cardiovascular events in these patients are tied to baseline status rather than any drug...” View full resource at thedoctorschannel.com
Most Recently Shared on February 27, 2012 at 7:31 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Don't jump to conclusions ... especially in matters of the heart! - From Reuters Health/TDC http://t.co/cy2Q0cr0 #health #heart #PPI
MedWire News - Thrombosis - Early stent thrombosis predictors identified
medwire-news.md — “MedWire News Variants in three genes associated with clopidogrel metabolism and platelet receptor function are independently associated with early stent thrombosis in patients undergoing percutaneous coronary intervention, study data show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on October 27, 2011 at 9:25 am By:
Early stent thrombosis predictors identified http://t.co/e1Dcb2dA
In the Literature: The latest research you need to know :: Article - The Hospitalist
the-hospitalist.org — “In This Edition Literature At A Glance A guide to this monthrsquos studies High-dose vs. low-dose clopidogrel after cardiac stenting Rates of overdiagnosis of PE with CTPA Outcomes of hospitalists with PAs or residents White coats and MRSA Correlation of vital signs and pain Rate of asymptomatic perioperative MI Relationship of opioid prescription...” View full resource at the-hospitalist.org
Most Recently Shared on September 8, 2011 at 10:28 pm By:
Physician Assistants Health News Feed
Hospitalist-PA teams might result in a slightly increased length-of-stay compared with the traditional resident teams: http://t.co/C6lCVQp
Emergency Medicine Article | Acute Coronary Syndrome
mdlinx.com — “Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome” View full resource at mdlinx.com
Most Recently Shared on September 2, 2011 at 12:15 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders... http://t.co/IONGFyB #ER
GRAVITAS Platelet Testing Gets a Second Look (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “PARIS (MedPage Today) -- On-treatment platelet reactivity was associated with the occurrence of adverse cardiovascular events in patients treated with clopidogrel (Plavix) after percutaneous coronary intervention (PCI) with a drug-eluting stent, a secondary analysis of the GRAVITAS trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on September 1, 2011 at 7:00 pm By:
GRAVITAS Platelet Testing Gets a Second Look (CME/CE): PARIS (MedPage Today) -- On-treatment platelet reactivity w... http://t.co/UKzP1jL
How Long One Can Use (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “I have been using clopidogrel 75mg aspirin 75 combination since last 21 months on my doctors advise As such I do not have any problem with the drugs and I am feeling much better now I have been operated and CABG on LAD was done in the year 2000 and PTCA on LAD with stunt was done in 1999 which reste (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on August 29, 2011 at 5:34 am By:
" Hello, Can you please answer the followung questions: What I understand is that first PTCA was carried out http://t.co/s1cScif
Do PPIs interact with aspirin? - - Drug Topics
drugtopics.modernmedicine.com — “Much ongoing research and discussion concerns the risks of using proton pump inhibitors with clopidogrel.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 13, 2011 at 4:09 am By:
Drugs and Devices OW OW Health
Do PPIs interact with aspirin?: Much ongoing research and discussion concerns the risks of using proton pump inh... http://t.co/Vwh1WFt
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
hindawi.com — “Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side effects. Clopidogrel major adverse events are represented by marrow suppression, manifesting with aplastic anaemia, thrombocytopenia and neutropenia. When clopidogrel toxicity occurs, there are few and ” View full resource at hindawi.com
Most Recently Shared on August 11, 2011 at 5:48 pm By:
Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?: We report a case of ... http://bit.ly/qZmVOm
Internal Medicine - Cardiology Article | Acute Coronary Syndrome
mdlinx.com — “The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients with acute coronary syndrome” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 7:25 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Internal Medicine - Cardiology Article | Acute Coronary Syndrome http://bit.ly/q4hxcu #Health #medicine
Emergency Medicine Article | Acute Coronary Syndrome
mdlinx.com — “The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients with acute coronary syndrome” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 1:50 pm By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients w... http://bit.ly/q4k0Do #ER
Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel | Journal of Invasive Cardiology
invasivecardiology.com — “Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on July 28, 2011 at 3:37 pm By:
Invasive Cardiology Cardiology and Medical Journal
Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel. http://t.co/4hc03eO
Internal Medicine - Cardiology Article | Myocardial infarction
mdlinx.com — “Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 7:08 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Internal Medicine - Cardiology Article | Myocardial infarction: http://t.co/Iw8hZ85 #Medicine
Family Medicine Article | Drug-eluting stents
mdlinx.com — “Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents” View full resource at mdlinx.com
Most Recently Shared on July 16, 2011 at 8:33 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardio... http://bit.ly/nQvyIP #FamPractice
Omega-3 and blood-thinning drugs impact clotting process
medicalxpress.com — “Researchers in Poland have discovered that combining omega-3 fatty acids with two blood-thinning drugs, aspirin and clopidogrel, changed the process of blood clotting, potentially helping reduce the risk of heart attacks in patients with stents in their heart arteries. The study's findings, which could ...” View full resource at medicalxpress.com
Most Recently Shared on June 21, 2011 at 6:37 pm By:
PhysOrg Health News Health News
Omega-3 and blood-thinning drugs impact clotting process http://tw.medicalxpress.com/227885819
Cardiology Article | Stents
mdlinx.com — “The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study” View full resource at mdlinx.com
Most Recently Shared on June 6, 2011 at 6:31 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
The impact of generic form of Clopidogrel on cardiovascular events in patients with coronary artery ... http://bit.ly/m7RZfR #cardiology
Advertisement
